Showing 2,821 to 2,832 of 7,969 results
Chinese Biotech Drug Outperforms Keytruda in Clinical Trials
Akeso's new lung cancer drug, Ivonescimab, outperformed Merck's Keytruda in Chinese clinical trials, extending progression-free survival; this success, coupled with increased licensing deals, highlights the rise of China's pharmaceutical innovation, though challenges in consumer trust and regulatory...
Chinese Biotech Drug Outperforms Keytruda in Clinical Trials
Akeso's new lung cancer drug, Ivonescimab, outperformed Merck's Keytruda in Chinese clinical trials, extending progression-free survival; this success, coupled with increased licensing deals, highlights the rise of China's pharmaceutical innovation, though challenges in consumer trust and regulatory...
Progress
48% Bias Score
Avian Flu Outbreak Drives Up Egg Prices in US
The highly pathogenic avian flu outbreak in the US has impacted over 18.91 million birds in the past 30 days, leading to high egg prices and prompting USDA Secretary Brooke Rollins to meet with farmers to find solutions; while culling remains the primary approach, vaccination faces challenges due to...
Avian Flu Outbreak Drives Up Egg Prices in US
The highly pathogenic avian flu outbreak in the US has impacted over 18.91 million birds in the past 30 days, leading to high egg prices and prompting USDA Secretary Brooke Rollins to meet with farmers to find solutions; while culling remains the primary approach, vaccination faces challenges due to...
Progress
48% Bias Score
Chinese Biotech Drug Outperforms Keytruda in Clinical Trials
Akeso, a Chinese biotech company, developed Ivonescimab, a lung cancer drug that outperformed Merck's Keytruda in clinical trials, resulting in a stock surge for its US partner and showcasing China's rising pharmaceutical innovation.
Chinese Biotech Drug Outperforms Keytruda in Clinical Trials
Akeso, a Chinese biotech company, developed Ivonescimab, a lung cancer drug that outperformed Merck's Keytruda in clinical trials, resulting in a stock surge for its US partner and showcasing China's rising pharmaceutical innovation.
Progress
40% Bias Score
DRC Outbreaks: 431 Illnesses, 53 Deaths, Cause Unknown
Two outbreaks in remote villages of the Democratic Republic of Congo's Equatoria Province have caused 431 illnesses and 53 deaths as of February 16th; the cause is unknown but tests for Ebola and Marburg were negative.
DRC Outbreaks: 431 Illnesses, 53 Deaths, Cause Unknown
Two outbreaks in remote villages of the Democratic Republic of Congo's Equatoria Province have caused 431 illnesses and 53 deaths as of February 16th; the cause is unknown but tests for Ebola and Marburg were negative.
Progress
32% Bias Score
China's BCI Push: New Standards and Action Plans
China's National Medical Products Administration approved new industry standards for BCI medical devices on February 25th, aiming to accelerate high-quality development and integration with AI in medicine, driven by an aging population and growing demand for neurological rehabilitation; Beijing and ...
China's BCI Push: New Standards and Action Plans
China's National Medical Products Administration approved new industry standards for BCI medical devices on February 25th, aiming to accelerate high-quality development and integration with AI in medicine, driven by an aging population and growing demand for neurological rehabilitation; Beijing and ...
Progress
48% Bias Score
France Updates Lyme Disease Guidelines, Emphasizing Multidisciplinary Approach
The French High Authority of Health (HAS) updated its Lyme disease guidelines on February 18th, acknowledging persistent symptoms but rejecting the chronic Lyme theory; it recommends a multidisciplinary approach focusing on patient symptoms and psychological factors, while studies reveal that 80-90%...
France Updates Lyme Disease Guidelines, Emphasizing Multidisciplinary Approach
The French High Authority of Health (HAS) updated its Lyme disease guidelines on February 18th, acknowledging persistent symptoms but rejecting the chronic Lyme theory; it recommends a multidisciplinary approach focusing on patient symptoms and psychological factors, while studies reveal that 80-90%...
Progress
36% Bias Score
GP Practices Accused of Patient Neglect Due to Unpaid Bills
Unpaid bills and staff shortages at three Northamptonshire GP practices, run by Dr. Jalil Ahmed and Dr. Jonathan Allinson, have led to unsafe conditions, equipment shortages, cancelled appointments, and compromised patient care, affecting over 20,000 patients and raising concerns about potential pat...
GP Practices Accused of Patient Neglect Due to Unpaid Bills
Unpaid bills and staff shortages at three Northamptonshire GP practices, run by Dr. Jalil Ahmed and Dr. Jonathan Allinson, have led to unsafe conditions, equipment shortages, cancelled appointments, and compromised patient care, affecting over 20,000 patients and raising concerns about potential pat...
Progress
48% Bias Score
Nuclear Fusion to Revolutionize Cancer Scans
Bristol-based Astral Systems developed a new method using nuclear fusion to produce radioisotopes for cancer scans, addressing supply chain issues and potentially revolutionizing cancer diagnosis, with smaller, cheaper plants built near hospitals.
Nuclear Fusion to Revolutionize Cancer Scans
Bristol-based Astral Systems developed a new method using nuclear fusion to produce radioisotopes for cancer scans, addressing supply chain issues and potentially revolutionizing cancer diagnosis, with smaller, cheaper plants built near hospitals.
Progress
60% Bias Score
FCI Scanner Shows Promise in Improving Breast Cancer Diagnosis and Treatment
A new scanner developed in Aberdeen, the Field Cycling Imager (FCI), shows potential to more accurately diagnose breast cancer than current MRI methods by varying magnetic field strength, reducing the need for repeat surgeries and improving treatment planning; initial trials on newly diagnosed patie...
FCI Scanner Shows Promise in Improving Breast Cancer Diagnosis and Treatment
A new scanner developed in Aberdeen, the Field Cycling Imager (FCI), shows potential to more accurately diagnose breast cancer than current MRI methods by varying magnetic field strength, reducing the need for repeat surgeries and improving treatment planning; initial trials on newly diagnosed patie...
Progress
40% Bias Score
UK's Antimicrobial Resistance Crisis: Limited Progress and Growing Threat
A report reveals that the UK is facing a growing crisis of antibiotic-resistant superbugs, with over 35,000 deaths annually and limited progress in government efforts to curb AMR, despite a national strategy launched in 2019; projections indicate a dramatic rise in AMR-related deaths globally.
UK's Antimicrobial Resistance Crisis: Limited Progress and Growing Threat
A report reveals that the UK is facing a growing crisis of antibiotic-resistant superbugs, with over 35,000 deaths annually and limited progress in government efforts to curb AMR, despite a national strategy launched in 2019; projections indicate a dramatic rise in AMR-related deaths globally.
Progress
52% Bias Score
USDA Announces $1 Billion Plan to Combat Avian Flu, but Egg Prices Projected to Soar
The USDA predicts a more than 40% increase in egg prices by 2025 due to avian flu, announcing a $1 billion investment in biosecurity, farmer aid, and vaccine research to combat the ongoing outbreak that has already resulted in the culling of over 166 million birds.
USDA Announces $1 Billion Plan to Combat Avian Flu, but Egg Prices Projected to Soar
The USDA predicts a more than 40% increase in egg prices by 2025 due to avian flu, announcing a $1 billion investment in biosecurity, farmer aid, and vaccine research to combat the ongoing outbreak that has already resulted in the culling of over 166 million birds.
Progress
40% Bias Score
Lemonade Recall: Undeclared Cancer-Linked Dye Prompts Nationwide Product Removal
Oak Cliff Beverage Works recalled over 16,000 units of its Beverage Base Lemonade due to undeclared Yellow 5, a synthetic dye linked to cancer, affecting consumers in eight states and raising concerns about food additive safety regulations.
Lemonade Recall: Undeclared Cancer-Linked Dye Prompts Nationwide Product Removal
Oak Cliff Beverage Works recalled over 16,000 units of its Beverage Base Lemonade due to undeclared Yellow 5, a synthetic dye linked to cancer, affecting consumers in eight states and raising concerns about food additive safety regulations.
Progress
52% Bias Score
Showing 2,821 to 2,832 of 7,969 results